Point72 Middle East Fze Regeneron Pharmaceuticals, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $2.02 Million - $2.3 Million
2,612 Added 315.46%
3,440 $3.02 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $573,348 - $699,138
828 New
828 $681,000
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $10.4 Million - $12.6 Million
-15,295 Reduced 98.07%
301 $247,000
Q4 2022

Feb 14, 2023
BUY
$705.89 - $766.39 $11 Million - $12 Million
15,596 New
15,596 $0

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email